Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 200 | 469 | 2 | 316 | 555 |
| Gross Profit | 200 | 469 | 2 | 316 | 555 |
| Operating Expenses | 1,922 | 3,256 | 2,854 | 2,122 | 2,155 |
| Operating Income | -1,721 | -2,787 | -2,851 | -1,806 | -1,600 |
| Interest Expense | 103 | 256 | 456 | 451 | 732 |
| Other Income | 0 | 0 | -1,194 | 0 | -78 |
| Pre-tax Income | -1,824 | -3,042 | -4,500 | -2,256 | -2,410 |
| Income Tax | 2 | N/A | N/A | N/A | 2 |
| Net Income Continuous | -1,826 | -3,042 | -4,500 | -2,256 | -2,411 |
| Net Income | $-1,826 | $-3,042 | $-4,500 | $-2,256 | $-2,411 |
| EPS Basic Total Ops | -3.30 | -5.41 | -8.41 | -4.50 | -6.61 |
| EPS Basic Continuous Ops | -3.26 | -5.49 | -8.43 | -4.45 | -6.52 |
| EPS Diluted Total Ops | -3.30 | -5.41 | -8.41 | -4.50 | -6.61 |
| EPS Diluted Continuous Ops | -3.26 | -5.49 | -8.43 | -4.45 | -6.52 |
| EBITDA(a) | $-1,685 | $-2,779 | $-2,546 | $-1,522 | $-1,175 |